T1	chemical 36 43	antigen
T2	disease_or_phenotypic_feature 47 62	gastric cancers
T3	chemical 74 83	serotonin
T4	chemical 93 103	inhibitors
T5	disease_or_phenotypic_feature 108 114	autism
T6	disease_or_phenotypic_feature 170 182	Wilms' tumor
T7	chemical 235 242	antigen
T8	chemical 265 274	serotonin
T9	chemical 284 294	inhibitors
T10	disease_or_phenotypic_feature 298 304	autism
T11	chemical 338 342	food
T12	disease_or_phenotypic_feature 354 372	metabolic disorder
T13	disease_or_phenotypic_feature 381 388	obesity
T14	disease_or_phenotypic_feature 393 401	diabetes
T15	chemical 415 426	pamidronate
T16	disease_or_phenotypic_feature 458 468	osteolysis
T17	chemical 472 483	biochemical
T18	chemical 505 515	Biomarkers
T19	disease_or_phenotypic_feature 532 545	breast cancer
T20	disease_or_phenotypic_feature 566 573	obesity
T21	chemical 591 601	inhibitors
T22	chemical 606 613	taurine
T23	disease_or_phenotypic_feature 652 659	obesity
T24	disease_or_phenotypic_feature 661 685	Congestive heart failure
T25	chemical 710 714	drug
T26	disease_or_phenotypic_feature 787 800	breast cancer
T27	chemical 844 851	gelatin
T28	chemical 852 859	polymer
T29	chemical 921 930	inhibitor
T30	corrected_chemical 1042 1072;932 944	combined with a cancer vaccine cabozantinib
T31	disease_or_phenotypic_feature 1058 1064	cancer
T32	chemical 1074 1083	Patiromer
T33	disease_or_phenotypic_feature 1101 1115	kidney disease
T34	disease_or_phenotypic_feature 1120 1132	hyperkalemia
T35	chemical 1148 1158	inhibitors
T36	chemical 1166 1169	CBD
T37	chemical 1226 1229	CBD
T38	chemical 1238 1242	drug
T39	chemical 1243 1247	drug
T40	disease_or_phenotypic_feature 1285 1293	diarrhea
T41	disease_or_phenotypic_feature 1304 1312	vomiting
T42	chemical 1362 1367	toxin
T43	disease_or_phenotypic_feature 1372 1382	spasticity
T44	disease_or_phenotypic_feature 1387 1395	dystonia
T45	chemical 1418 1432	mTOR inhibitor
T46	chemical 1433 1446	ridaforolimus
T47	chemical 1455 1469	HDAC inhibitor
T48	chemical 1470 1480	vorinostat
T49	disease_or_phenotypic_feature 1493 1513	renal cell carcinoma
T50	chemical 1538 1541	Ten
T51	disease_or_phenotypic_feature 1554 1562	melanoma
T52	chemical 1599 1607	estrogen
T53	chemical 1654 1671	local anaesthetic
T54	chemical 1672 1679	mixture
T55	disease_or_phenotypic_feature 1684 1690	cancer
T56	disease_or_phenotypic_feature 1691 1695	pain
T57	chemical 1698 1702	Acid
T58	chemical 1703 1707	base
T59	chemical 1708 1715	balance
T60	disease_or_phenotypic_feature 1780 1792	cleft palate
T61	chemical 1795 1805	Ketanserin
T62	chemical 1846 1850	drug
T63	disease_or_phenotypic_feature 1885 1898	heart failure
T64	disease_or_phenotypic_feature 1910 1916	asthma
T65	chemical 1933 1937	food
T66	disease_or_phenotypic_feature 1984 1999	speech disorder
T67	corrected_chemical 255 294	selective serotonin reuptake inhibitors
T68	corrected_disease_or_phenotypic_feature 298 304;309 326	autism related disorders
R1	treats Arg1:T67 Arg2:T10	
R2	treats Arg1:T67 Arg2:T68	
T69	corrected_chemical 328 342	Excessive food
R3	causes_or_contributes_to Arg1:T69 Arg2:T13	
R4	causes_or_contributes_to Arg1:T69 Arg2:T14	
T70	corrected_disease_or_phenotypic_feature 444 468	tumor-induced osteolysis
T72	corrected_chemical 585 601	PTP1B inhibitors
T73	corrected_disease_or_phenotypic_feature 641 659	adolescent obesity
R6	treats Arg1:T72 Arg2:T73	
R7	treats Arg1:T22 Arg2:T73	
T74	missed_disease_or_phenotypic_feature 949 987	immune-mediated killing of tumor cells
T75	missed_disease_or_phenotypic_feature 1262 1283	hepatic abnormalities
R10	causes_or_contributes_to Arg1:T37 Arg2:T75	
R11	causes_or_contributes_to Arg1:T37 Arg2:T40	
T76	missed_disease_or_phenotypic_feature 1295 1302	fatigue
R12	causes_or_contributes_to Arg1:T37 Arg2:T76	
R13	causes_or_contributes_to Arg1:T37 Arg2:T41	
T77	missed_disease_or_phenotypic_feature 1318 1328	somnolence
R14	causes_or_contributes_to Arg1:T37 Arg2:T77	
T78	corrected_chemical 1143 1158	RAAS inhibitors
R15	treats Arg1:T78 Arg2:T33	
T79	missed_disease_or_phenotypic_feature 1238 1260	drug-drug interactions
R16	causes_or_contributes_to Arg1:T37 Arg2:T79	
T80	corrected_chemical 1352 1367	botulinum toxin
R17	treats Arg1:T80 Arg2:T43	
R18	treats Arg1:T80 Arg2:T44	
R19	treats Arg1:T45 Arg2:T49	
R20	treats Arg1:T46 Arg2:T49	
R21	treats Arg1:T47 Arg2:T49	
R22	treats Arg1:T48 Arg2:T49	
T81	missed_disease_or_phenotypic_feature 1524 1536	solid tumors
R23	treats Arg1:T45 Arg2:T81	
R24	treats Arg1:T46 Arg2:T81	
R25	treats Arg1:T47 Arg2:T81	
R26	treats Arg1:T48 Arg2:T81	
T82	corrected_chemical 1647 1679	opioid/local anaesthetic mixture
T83	corrected_disease_or_phenotypic_feature 1684 1695	cancer pain
R27	treats Arg1:T82 Arg2:T83	
R28	treats Arg1:T61 Arg2:T63	
T84	corrected_chemical 1834 1850	vasodilator drug
R29	treats Arg1:T84 Arg2:T63	
T86	missed_disease_or_phenotypic_feature 992 1036	immune tumor microenvironment permissiveness
T87	corrected_chemical 1042 1072;906 930	combined with a cancer vaccine small-molecule inhibitor
T85	chemical 932 944	cabozantinib
T88	missed_disease_or_phenotypic_feature 1182 1190	epilepsy
T89	missed_disease_or_phenotypic_feature 1195 1216	psychiatric disorders
T90	missed_disease_or_phenotypic_feature 1330 1346	Chemodenervation
R35	causes_or_contributes_to Arg1:T80 Arg2:T90	
T91	missed_disease_or_phenotypic_feature 1632 1641	analgesia
R36	causes_or_contributes_to Arg1:T82 Arg2:T91	
R9	treats Arg1:T78 Arg2:T34	
R5	treats Arg1:T15 Arg2:T70	
R8	treats Arg1:T36 Arg2:T88	
R30	treats Arg1:T36 Arg2:T89	
